HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -78.3% | 8,000 | -73.6% | 0.00% | -100.0% |
| Q3 2021 | $46,000 | -23.3% | 30,300 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $60,000 | +3.4% | 30,300 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $58,000 | -32.6% | 31,300 | -20.4% | 0.00% | -50.0% |
| Q4 2020 | $86,000 | -11.3% | 39,300 | +16.3% | 0.01% | -33.3% |
| Q2 2020 | $97,000 | +56.5% | 33,800 | -2.9% | 0.01% | +28.6% |
| Q1 2020 | $62,000 | -11.4% | 34,800 | +165.4% | 0.01% | +40.0% |
| Q4 2019 | $70,000 | – | 13,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
| Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
| PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
| Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
| Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
| Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |